1. Home
  2. SCM vs RAPP Comparison

SCM vs RAPP Comparison

Compare SCM & RAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCM
  • RAPP
  • Stock Information
  • Founded
  • SCM 2012
  • RAPP 2022
  • Country
  • SCM United States
  • RAPP United States
  • Employees
  • SCM N/A
  • RAPP N/A
  • Industry
  • SCM Finance/Investors Services
  • RAPP
  • Sector
  • SCM Finance
  • RAPP
  • Exchange
  • SCM Nasdaq
  • RAPP Nasdaq
  • Market Cap
  • SCM 397.8M
  • RAPP 439.4M
  • IPO Year
  • SCM 2012
  • RAPP 2024
  • Fundamental
  • Price
  • SCM $12.85
  • RAPP $28.54
  • Analyst Decision
  • SCM Hold
  • RAPP Strong Buy
  • Analyst Count
  • SCM 1
  • RAPP 4
  • Target Price
  • SCM $13.00
  • RAPP $37.00
  • AVG Volume (30 Days)
  • SCM 223.5K
  • RAPP 1.8M
  • Earning Date
  • SCM 11-06-2025
  • RAPP 11-06-2025
  • Dividend Yield
  • SCM 12.45%
  • RAPP N/A
  • EPS Growth
  • SCM 11.71
  • RAPP N/A
  • EPS
  • SCM 1.43
  • RAPP N/A
  • Revenue
  • SCM $102,761,445.00
  • RAPP N/A
  • Revenue This Year
  • SCM N/A
  • RAPP N/A
  • Revenue Next Year
  • SCM $1.23
  • RAPP N/A
  • P/E Ratio
  • SCM $8.96
  • RAPP N/A
  • Revenue Growth
  • SCM N/A
  • RAPP N/A
  • 52 Week Low
  • SCM $11.19
  • RAPP $6.43
  • 52 Week High
  • SCM $15.56
  • RAPP $42.27
  • Technical
  • Relative Strength Index (RSI)
  • SCM 23.15
  • RAPP 62.63
  • Support Level
  • SCM $12.74
  • RAPP $26.00
  • Resistance Level
  • SCM $14.04
  • RAPP $30.72
  • Average True Range (ATR)
  • SCM 0.29
  • RAPP 2.11
  • MACD
  • SCM -0.09
  • RAPP -0.07
  • Stochastic Oscillator
  • SCM 8.13
  • RAPP 65.34

About SCM Stellus Capital Investment Corporation

Stellus Capital Investment Corp is a closed-end, non-diversified management investment company. Its objective is to maximize the total return to its stockholders in the form of current income and capital appreciation. It invests in private middle-market companies through a first lien, second lien, and unsecured debt financing, often with a corresponding equity investment. The company invests in various sectors, such as business services, energy, general industrial, government services, healthcare, software, and specialty finance. The business activity of the firm is functioned through the United States and it generates revenue in the form of interest income on debt investments and capital gains and distributions.

About RAPP Rapport Therapeutics Inc. Common Stock

Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.

Share on Social Networks: